Move it or lose it: exploiting genetic diversity to fight extinction

By Dr Ben Phillips, Dr Andrew Weeks and Professor Ary Hoffmann, School of Biosciences, University of Melbourne.

Media Release: CSL Announces $25 million Centenary Fellowship Program

CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia

SARTATE trial results to be presented at the upcoming 2016 SNMMI Meeting

Clarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).

Media Release: Flexi is sexy for malaria parasite

Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.

The Governor of Victoria visits the Bio21 Institute

Dr Andrew Cuthbertson, CSL Chief Scientific Officer, The Governor of Victoria, The Honourable Linda Dessau, The Chancellor, Elizabeth Alexander AM, Dr Andrew Nash, Senior Vice President, Research, CSL Ltd.

Biochemistry and Molecular Biology Seminar Series presents Stephen Batinovic, PhD Oration

Wednesday, 6 April, 2016 - 12:00 to 13:00

“A network of protein interactions required for trafficking of PfEMP1 in P. falciparum infected erythrocytes” 


Subscribe to Bio21 Molecular Science & Biotechnology Institute RSS